Keywords: CEST / APT / NOE, Radiotherapy
Motivation: Routine MRI struggles to differentiate tumor progression from treatment-induced changes in glioma patients after chemoradiotherapy (CRT). Chemical exchange saturation transfer (CEST) yields metabolic information and could support a reliable differentiation.
Goal(s): To explore potentially different CEST contrast changes in normal-appearing brain tissue and gliomas after CRT.
Approach: Prospective clinical trial of 3 Tesla CEST MRI before CRT (photons and protons) and up to seven months thereafter.
Results: CEST contrasts remain unchanged in white and gray matter that received up to 60 Gray. However, CEST contrasts change inside gliomas, and the APT-weighted contrast develops differently in progressive versus non-progressive tumors.
Impact: CEST contrasts remain unchanged in normal-appearing brain tissue after radiotherapy but change inside gliomas. Based on these findings, CEST contrast changes in gliomas after radiotherapy should be considered to be tumor-specific, and may be used to support tumor response assessment.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords